Press release
Elevating Prevalence Of Liver Diseases Fuels Growth In Liver Disease Therapeutics Market: Key Factor Driving The Growth In The Liver Diseases Therapeutics Market
Liver Diseases Therapeutics
What Is the Expected Liver Diseases Therapeutics Market Size During the Forecast Period?
The market size for therapeutics for liver diseases has been experiencing robust growth in the past few years. It's projected to rise from $14.16 billion in 2024 to an impressive $15.23 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. This growth during the historical period is due to factors like a high incidence of liver diseases, patterns of alcohol consumption, developments in diagnostic techniques, obesity and metabolic syndrome conditions, consciousness and screening campaigns, and government-led hepatitis control initiatives.
Expectations are high for substantial expansion in the liver diseases therapeutics market size in the upcoming years. Forecasts predict growth to $20.78 billion by 2029 with a compound annual growth rate (CAGR) of 8.1%. The enhanced growth in the forecast period is due to the adoption of precision medicine methods, advances in RNA therapeutics, an emphasis on fibrosis treatments, patient backing and support groups, hepatitis vaccine developments, and regulatory support for rare disease drugs. Anticipated trends for the forecast period encompass advancements in Hepatitis C treatment, emergence of innovative therapies for liver fibrosis, exploration of immunotherapies, implementation of telemedicine and remote monitoring, and a focus on nutritional interventions.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7969
What Are the High-Growth Segments in the Liver Diseases Therapeutics Market?
The liver diseases therapeutics market covered in this report is segmented -
1) By Disease Type: Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer
2) By Treatment: Antiviral, Vaccines, Chemotherapy, Immunosuppressive Agents, Corticosteroids
3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users
Subsegments:
1) By Hepatitis: Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D
2) By Non-Alcoholic Fatty Liver Disease (NAFLD): Non-Alcoholic Steatohepatitis (NASH), Simple Fatty Liver
3) By Alcohol-Induced Liver Disease: Alcoholic Hepatitis, Alcoholic Cirrhosis
4) By Liver Cancer: Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7969&type=smp
What Key Drivers Are Expected to Influence Future Liver Diseases Therapeutics Market Growth?
The increase in liver disease cases is anticipated to fuel the expansion of the liver disease therapeutics market. Liver disease pertains to any malady that impacts the liver, and these therapeutics offer various methods to treat these liver illnesses. For example, data from the Office for Health Improvement and Disparities, a government agency in the UK, report that the rate of fatalities due to liver disease for those under the age of 75 in England rose to 21.4 per 100,000 people in 2022. Particularly, males had 6,664 early deaths compared to 3,929 for females. Thus, the escalating frequency of liver diseases is fostering the augmentation of the liver disease therapeutics market.
Which Companies Hold the Largest Share Across Different Liver Diseases Therapeutics Market Segments?
Major companies operating in the liver diseases therapeutics market are Astellas Pharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, GlaxoSmithKline PLC, Abbott Laboratories Inc., Pfizer Inc., Sanofi SA, Johnson & Johnson Services Inc., Bayer AG, AbbVie Inc., Takeda Pharmaceutical Company Limited, Valeant Pharmaceuticals, Watson Pharmaceuticals Inc., AstraZeneca PLC, Gilead Sciences Inc., Endo International PLC, Alnylam Pharmaceuticals Inc., Provectus Biopharmaceuticals Inc., Intercept Pharmaceuticals Inc., Conatus Pharmaceuticals Inc., CymaBay Therapeutics Inc., Viking Therapeutics Inc., Madrigal Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Enanta Pharmaceuticals Inc.
What Trends Are Driving Growth in The Liver Diseases Therapeutics Market?
The evolution of strategic alliances is a noteworthy trend gaining traction in the liver disease therapeutics market. Renowned firms functioning in the liver disease therapy sphere are pursuing collaborations to fortify their stake in the market. For instance, in January 2022, Aligos Therapeutics Inc., a clinical-stage biopharmaceutical establishment based in the US, formed an alliance with Merck & Co, a firm also originating from the US that specializes in liver disease therapeutics. The objective behind this collaboration is to pioneer and advance oligonucleotide treatments for non-alcoholic steatohepatitis.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report
What Are the Emerging Geographies for The Liver Diseases Therapeutics Market Growth?
North America was the largest region in the liver diseases therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the liver diseases therapeutics market report during the forecast period. The regions covered in the liver diseases therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Liver Diseases Therapeutics Market?
2. What is the CAGR expected in the Liver Diseases Therapeutics Market?
3. What Are the Key Innovations Transforming the Liver Diseases Therapeutics Industry?
4. Which Region Is Leading the Liver Diseases Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Elevating Prevalence Of Liver Diseases Fuels Growth In Liver Disease Therapeutics Market: Key Factor Driving The Growth In The Liver Diseases Therapeutics Market here
News-ID: 3970848 • Views: …
More Releases from The Business Research Company
2025-2034 RegTech Market Roadmap: Insights for Competitive Advantage
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the RegTech Market Through 2025?
In recent times, the regtech market scale has experienced swift growth. It is projected to expand from a value of $16.18 billion in 2024 to $18.92 billion in 2025, representing a compound annual growth rate (CAGR) of 17.0%.…
Emerging Rail Transport Market Trends: Growing Role Of Adas Technology In Rail T …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Rail Transport Industry Market Size Be by 2025?
In recent times, there has been a robust expansion in the rail transport market, with projections estimating its growth from $590.53 billion in 2024 to $633.75 billion in 2025. This reflects a 7.3% compound annual growth rate (CAGR).…
The Role of Digitalization in Accelerating Product Lifecycle Management Market G …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Product Lifecycle Management Market Size By 2025?
In recent times, the market size for product lifecycle management has experienced robust growth. This market is projected to expand from $38.92 billion in 2024 to $41.28 billion in 2025, with a compound annual growth rate (CAGR) of…
Precast Concrete Market on Track for Strong Growth, Estimated to Grow at 5.8% CA …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Precast Concrete Market Size Growth Forecast: What to Expect by 2025?
There has been consistent growth in the precast concrete market size over the past few years. The market size stands at $124.26 billion in 2024 and is projected to rise to $129.49 billion in 2025, representing a compound…
More Releases for Liver
Acute on Chronic Liver Failure Market Impacts Liver Disease Patients By 2031
Global Acute On Chronic Liver Failure Market reached at a CAGR during the forecast period 2024-2031.
Acute On Chronic Liver Failure Market, as detailed in the DataM Intelligence report, presents a strategic overview of the industry backed by in-depth data and market trends. The study highlights the performance and positioning of major players, focusing on their offerings, pricing models, financial outcomes, and growth strategies. It serves as a concise yet insightful…
Sandhus Nutrition Launches Powerful Liver Cleanse and Detox Formula for Support …
Image: https://www.getnews.info/wp-content/uploads/2024/10/1730406894.png
Featuring 11 powerful, science-backed ingredients, this new supplement supports liver cleanse, detox, and overall wellness.
Sandhus Nutrition, a health and wellness company, is thrilled to announce the launch of its new Liver Cleanse and Detox formula. This formula is designed to help liver health and support the body's natural detoxification process. It combines 11 potent ingredients that support liver cleanse, detox, and repair, making it an essential addition to any…
LivCare Liver Support
The liver plays a crucial role in maintaining overall well-being, performing essential functions like detoxification, digestion, and metabolism. However, many people overlook the importance of liver health until problems arise. LivCare Liver Support is a premium supplement designed to keep your liver in peak condition. By incorporating this supplement into your daily routine, you can help ensure your liver functions optimally, leading to better overall health.
● Product Name - LivCare…
Liver Cancer Therapeutics Market - Fueling Hope, Fighting Liver Cancer: Discover …
Newark, New Castle, USA: The "Liver Cancer Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Liver Cancer Therapeutics Market: https://www.growthplusreports.com/report/liver-cancer-therapeutics-market/7811
This latest report researches the industry structure,…
Liver Cancer Therapeutics Market - Empowering Recovery, Restoring Health: Innova …
Newark, New Castle, USA - new report, titled Liver Cancer Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liver Cancer Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liver Cancer Therapeutics market. The report offers an overview of…
Liver Health Supplements Market Grows Strong as Consumers Adopt Proactive Measur …
Global liver health supplements market was valued at US$ 8.7 Bn in 2021, is growing at an estimated CAGR of 5.8% over the forecast period (2022 - 2030). The liver health supplements market is growing due to the increasing awareness of the importance of liver health and the rise of lifestyle-related liver diseases. The market offers a wide range of supplements that help in improving liver function, supporting liver detoxification,…
